Group 1 - The core viewpoint of the news is the performance and structure of the Zhonghai Healthcare Theme Stock A fund, which has seen a decline in recent trading days and has a significant portion of its holdings in specific pharmaceutical companies [1][2][3] Group 2 - As of June 19, Zhonghai Healthcare Theme Stock A has decreased by 1.28%, with a latest net value of 1.08 yuan, marking a cumulative decline of 8.09% over five consecutive trading days [1] - The fund was established in March 2012, with a total fund size of 519 million yuan and a cumulative return of 172.08% since inception [1] - The holder structure shows that as of the end of 2024, institutional investors hold 5.9 million shares (10.54% of total shares), while individual investors hold 49.8 million shares (89.46% of total shares) [1] - The current fund manager, Liang Jingjing, has a background in pharmaceutical chemistry and has held various research positions before becoming the fund manager [1] - As of March 31, 2025, the top ten holdings of the fund account for a total of 67.74%, with notable companies including Zai Lab (9.84%), BeiGene (8.53%), and WuXi AppTec (7.14%) [2]
中海医疗保健主题股票A连续5个交易日下跌，区间累计跌幅8.09%
Sou Hu Cai Jing·2025-06-19 16:30